Skaarup KG, Davidovski FS, Durukan E, Rastoder E,. Inflammation and Cardiac Dysfunction in Hospitalized Patients With Influenza: The FluHeart Study. Influenza Other Respir Viruses. 2026 May;20(5):e70
Background: Influenza virus infection can lead to acute cardiovascular events, but the relationship between influenza-induced inflammation and cardiac dysfunction remains unclear. This study evaluated whether the severity of inflammation was associated with cardiac impairment, as assessed by echocardiography, in hospitalized patients with influenza.
Methods: In this prospective cohort study conducted in Denmark across three influenza seasons (2021-2022, 2022-2023, and 2023-2024), consecutive hospitalized patients with laboratory-confirmed influenza underwent protocolized echocardiography. Associations between C-reactive protein (CRP) levels and measures of cardiac function were assessed using multivariable models.
Results: Among 241 patients (median age, 73.2 years; IQR, 58.3-82.8; 53% female), 54% had left ventricular (LV) systolic dysfunction (ejection fraction < 50% or global longitudinal strain < 16%), 15% had signs of elevated LV filling pressure (E/e´ ≥ 14), 29% had right ventricular (RV) systolic dysfunction (tricuspid annular plane systolic excursion [TAPSE] < 1.7 cm or RV free wall strain < 20%), and 31% had pulmonary hypertension (RV systolic pressure [RVSP] > 40 mmHg). CRP showed a significant nonlinear association with E/e´, RVSP, and TAPSE. E/e´ and TAPSE worsened with higher CRP up to 100 mg/L, plateauing thereafter, whereas RVSP worsened at CRP levels > 100 mg/L.
Conclusions: Cardiac dysfunction was observed in more than half of all examined hospitalized patients with influenza. Higher levels of inflammation were independently associated with elevated LV filling pressure, pulmonary hypertension, and RV dysfunction, supporting a potential link between influenza infection and cardiac impairment.
Methods: In this prospective cohort study conducted in Denmark across three influenza seasons (2021-2022, 2022-2023, and 2023-2024), consecutive hospitalized patients with laboratory-confirmed influenza underwent protocolized echocardiography. Associations between C-reactive protein (CRP) levels and measures of cardiac function were assessed using multivariable models.
Results: Among 241 patients (median age, 73.2 years; IQR, 58.3-82.8; 53% female), 54% had left ventricular (LV) systolic dysfunction (ejection fraction < 50% or global longitudinal strain < 16%), 15% had signs of elevated LV filling pressure (E/e´ ≥ 14), 29% had right ventricular (RV) systolic dysfunction (tricuspid annular plane systolic excursion [TAPSE] < 1.7 cm or RV free wall strain < 20%), and 31% had pulmonary hypertension (RV systolic pressure [RVSP] > 40 mmHg). CRP showed a significant nonlinear association with E/e´, RVSP, and TAPSE. E/e´ and TAPSE worsened with higher CRP up to 100 mg/L, plateauing thereafter, whereas RVSP worsened at CRP levels > 100 mg/L.
Conclusions: Cardiac dysfunction was observed in more than half of all examined hospitalized patients with influenza. Higher levels of inflammation were independently associated with elevated LV filling pressure, pulmonary hypertension, and RV dysfunction, supporting a potential link between influenza infection and cardiac impairment.
See Also:
Latest articles in those days:
- Avian Influenza in Humans: Virology, Transmission, and Clinical Priorities 15 hours ago
- Global influenza epidemiology after 2020: patterns of circulation, epidemic timing and duration, and implications for vaccination strategies 1 days ago
- Coding complete genome of LPAI H16N3 virus from Australia suggests intercontinental movement 2 days ago
- Detection of antibodies to avian influenza virus H5N1 clade 2.3.4.4b in naturally infected cattle for more than a year 2 days ago
- A C-type single-domain antibody with protective efficacy against H1N1 via respiratory administration 2 days ago
[Go Top] [Close Window]


